Add : Balamut , Fri, 10 Sep 2010 07:34:59 +0000 |
Edit
New Articles : ASTRAZENECA
DJ UPDATE Aurobindo Pharma In Licensing Supply Pacts With ...
DJ UPDATE: Aurobindo Pharma In Licensing, Supply Pacts With AstraZeneca Mon Sep 06 02:19:25 2010 EDT (Adds comments from Aurobindo and.
|
AstraZeneca Rises 0.49% on Heavy Volume: Watch For Pullback (AZN ...
AstraZeneca (NYSE:AZN) traded in a range yesterday that spanned from a low of $51.25 to a high of $51.89. Yesterday, the shares gained 0.49%, which took the trading range above the 3-day high of $51.26 on volume of 1.2 million shares. ...
|
DJ AstraZeneca PLC Transaction in Own Shares | Cmemarkets.com ...
DJ AstraZeneca PLC Transaction in Own Shares Mon Sep 06 02:00:28 2010 EDT TIDMAZN RNS Number : 1650S AstraZeneca PLC 06 September.
|
Red Signal For AstraZeneca Drug | DailyMarkets.com
AstraZeneca plc ] recently announced that its biologics unit, MedImmune, received yet another Complete Response Letter (CRL) from the US Food and Drug.
|
AstraZeneca Inks Agreement | DailyMarkets.com
Recently, AstraZeneca PLC ] and India based generic company Aurobindo Pharma Ltd. inked a licensing and supply agreement aimed at enabling the Indian company.
|
Free e-Learning Module: Endocrine Therapy for Transgender Patients ...
View full campaign : Free e-Learning Modules by AstraZeneca: Relevant training and resources to help frontline health practitioners understand and address the health issues of their clients. View all content from : AstraZeneca Canada ...
|
AstraZeneca PLC: Director/PDMR Shareholding | Company ...
Investegate, Announcements from AstraZeneca PLC, Announcement Name.
|
Red Signal for AstraZeneca Drug - Zacks.com
Red Signal for AstraZeneca Drug-AstraZeneca's RSV candidate, motavizumab, received yet another Complete Response Letter from the FDA.
|
AstraZeneca in deal with India's Aurobindo to supply branded ...
In another move by a pharmaceutical major to prop up falling revenues from original drugs in developed markets, Anglo-Swedish drugmaker AstraZeneca has reached an accord with Hyderabad, India-headquartered Aurobindo Pharma to supply ...
|
PharmaGossip: AstraZeneca Given More Time to Settle 6000 Seroquel ...
AstraZeneca, the U.K.'s second-biggest drugmaker, still faces at least 8000 cases in both state and federal courts alleging Seroquel causes diabetes in some users. The drugmaker won the first jury trial over those claims in state court ...
|
|
|